论文部分内容阅读
1986年上海国际肝癌与肝炎会议共邀请15位国内外肝癌研究知名学者作专题演讲,包括美国5人(Vyas,Shafritz,Wands,London,Shaw),中国4人(吴孟超,顾健人,俞顺章,汤钊猷),日本2人(Okuda,Tobe),西德(Hofschneider)、法国(Tiollais)、新加坡(Oon)与泰国(Viranuvatti书面发言)各1人,从而在一定程度上反映了世界肝癌研究动向.亚洲国家肝癌研究现状1986年1月先后在新加坡、上海、东京举行了三个国际肝病会议,称为亚洲肝病年.日本、中国、泰国和新加坡基本上反映了亚洲的情况.就总的说,我国自六十年代起步,尤其七十年代以来肝癌防治研究发展迅速,其中现场、临床、基础三结合,有我国特色,如证实N-ras是
In 1986, Shanghai International Forum on Hepatology and Hepatology invited 15 well-known scholars from home and abroad to make keynote speeches, including 5 from the United States (Vyas, Shafritz, Wands, London, Shaw), 4 from China (Wu Mengchao, Gu Jianren, Yu Shunzhang, Tang Zhao 猷), Japan (Okuda, Tobe), Germany (Hofschneider), France (Tiollais), Singapore (Oon) and Thailand (Viranuvatti written statement) each one, thus reflecting the trend of the world’s liver cancer research to some extent. Current Status of Liver Cancer Research in Asian Countries In January 1986, three international liver disease conferences were successively held in Singapore, Shanghai and Tokyo, known as the Year of Asia, with Japan, China, Thailand and Singapore basically reflecting the situation in Asia. In general, Since the sixties of the start of our country, especially since the seventies, rapid development of prevention and treatment of liver cancer, including on-site, clinical, basic three combined with our own characteristics, as confirmed N-ras is